Odyssey-backed ProPharma acquires Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a provider of regulatory affairs, pharmacovigilance, and compliance and quality services for pharmaceutical and biotechnology companies.